Drug Target Review2025-01-23T08:00:09
Grifols has received a $21 million grant from The Michael J. Fox Foundation to fund a pioneering study aimed at identifying early biomarkers for Parkinson's disease (PD).
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-08-20T08:43:00Z
Author Dr Daniel Tillett
2026-08-17T14:16:00
Contributor Dr Rab Prinjha, Drug Target Review
2023-11-20T13:43:43
Sponsored by Merck
2025-03-19T15:00:00
Sponsored by Eurofins DiscoverX
2025-11-13T14:00:00
Sponsored by Cell Signaling Technology
2026-05-12T09:31:00
Contributor Sugish Pillai, Axel Ziemke and Dr Gary Kusdian
2024-02-07T14:34:33
Sponsored by BellBrook Labs
Site powered by Webvision Cloud